Cargando…

Elimination of fukutin reveals cellular and molecular pathomechanisms in muscular dystrophy-associated heart failure

Heart failure is the major cause of death for muscular dystrophy patients, however, the molecular pathomechanism remains unknown. Here, we show the detailed molecular pathogenesis of muscular dystrophy-associated cardiomyopathy in mice lacking the fukutin gene (Fktn), the causative gene for Fukuyama...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ujihara, Yoshihiro, Kanagawa, Motoi, Mohri, Satoshi, Takatsu, Satomi, Kobayashi, Kazuhiro, Toda, Tatsushi, Naruse, Keiji, Katanosaka, Yuki
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6917736/ https://www.ncbi.nlm.nih.gov/pubmed/31848331 http://dx.doi.org/10.1038/s41467-019-13623-2

Ejemplares similares

TRPV2 is critical for the maintenance of cardiac structure and function in mice
por: Katanosaka, Yuki, et al.
Publicado: (2014)

Crystal structures of fukutin-related protein (FKRP), a ribitol-phosphate transferase related to muscular dystrophy
por: Kuwabara, Naoyuki, et al.
Publicado: (2020)

Fukutin is prerequisite to ameliorate muscular dystrophic phenotype by myofiber-selective LARGE expression
por: Ohtsuka, Yoshihisa, et al.
Publicado: (2015)

Muscular Dystrophy with Ribitol-Phosphate Deficiency: A Novel Post-Translational Mechanism in Dystroglycanopathy
por: Kanagawa, Motoi, et al.
Publicado: (2017)

TRPV2 is required for mechanical nociception and the stretch-evoked response of primary sensory neurons
por: Katanosaka, Kimiaki, et al.
Publicado: (2018)

Congenital hearing impairment associated with peripheral cochlear nerve dysmyelination in glycosylation-deficient muscular dystrophy
por: Morioka, Shigefumi, et al.
Publicado: (2020)

CDP-ribitol prodrug treatment ameliorates ISPD-deficient muscular dystrophy mouse model
por: Tokuoka, Hideki, et al.
Publicado: (2022)

Contribution of Dysferlin Deficiency to Skeletal Muscle Pathology in Asymptomatic and Severe Dystroglycanopathy Models: Generation of a New Model for Fukuyama Congenital Muscular Dystrophy
por: Kanagawa, Motoi, et al.
Publicado: (2014)

Novel fukutin mutations in limb-girdle muscular dystrophy type 2M with childhood onset
por: Smogavec, Mateja, et al.
Publicado: (2017)

Pathogenic exon-trapping by SVA retrotransposon and rescue in Fukuyama muscular dystrophy
por: Taniguchi-Ikeda, Mariko, et al.
Publicado: (2011)

Four-week rapamycin treatment improves muscular dystrophy in a fukutin-deficient mouse model of dystroglycanopathy
por: Foltz, Steven J., et al.
Publicado: (2016)

Roles of Fukutin, the Gene Responsible for Fukuyama-Type Congenital Muscular Dystrophy, in Neurons: Possible Involvement in Synaptic Function and Neuronal Migration
por: Hiroi, Atsuko, et al.
Publicado: (2011)

Fukutin regulates tau phosphorylation and synaptic function: Novel properties of fukutin in neurons
por: Tsukui, Ryota, et al.
Publicado: (2022)

Pathomechanisms and biomarkers in facioscapulohumeral muscular dystrophy: roles of DUX4 and PAX7
por: Banerji, Christopher R S, et al.
Publicado: (2021)

Involvement of S1P(1) receptor pathway in angiogenic effects of a novel adenosine-like nucleic acid analog COA-Cl in cultured human vascular endothelial cells
por: Igarashi, Junsuke, et al.
Publicado: (2014)

Clinical aspects, molecular pathomechanisms and management of myotonic dystrophies
por: MEOLA, GIOVANNI
Publicado: (2013)

Temporal requirement of dystroglycan glycosylation during brain development and rescue of severe cortical dysplasia via gene delivery in the fetal stage
por: Sudo, Atsushi, et al.
Publicado: (2018)

Galectin 3–binding protein suppresses amyloid-β production by modulating β-cleavage of amyloid precursor protein
por: Seki, Tsuneyoshi, et al.
Publicado: (2020)

Expression and purification of the transmembrane domain of Fukutin-I for biophysical studies
por: Marius, P., et al.
Publicado: (2010)

A multistage sequencing strategy pinpoints novel candidate alleles for Emery-Dreifuss muscular dystrophy and supports gene misregulation as its pathomechanism
por: Meinke, Peter, et al.
Publicado: (2019)

Antagonism Between DUX4 and DUX4c Highlights a Pathomechanism Operating Through β-Catenin in Facioscapulohumeral Muscular Dystrophy
por: Ganassi, Massimo, et al.
Publicado: (2022)

Probing the oligomeric state and interaction surfaces of Fukutin-I in dilauroylphosphatidylcholine bilayers
por: Marius, P., et al.
Publicado: (2011)

Zebrafish Fukutin family proteins link the unfolded protein response with dystroglycanopathies
por: Lin, Yung-Yao, et al.
Publicado: (2011)

Efficacy and muscle safety assessment of fukutin-related protein gene therapy
por: Benasutti, Halli, et al.
Publicado: (2023)

Characteristics of Japanese Patients with Becker Muscular Dystrophy and Intermediate Muscular Dystrophy in a Japanese National Registry of Muscular Dystrophy (Remudy): Heterogeneity and Clinical Variation
por: Mori-Yoshimura, Madoka, et al.
Publicado: (2018)

Autologous intramuscular transplantation of engineered satellite cells induces exosome-mediated systemic expression of Fukutin-related protein and rescues disease phenotype in a murine model of limb-girdle muscular dystrophy type 2I
por: Frattini, Paola, et al.
Publicado: (2017)

In silico drug screening by using genome-wide association study data repurposed dabrafenib, an anti-melanoma drug, for Parkinson’s disease
por: Uenaka, Takeshi, et al.
Publicado: (2018)

Characterization of dystroglycan binding in adhesion of human induced pluripotent stem cells to laminin-511 E8 fragment
por: Sugawara, Yumika, et al.
Publicado: (2019)

Pathomechanism of intervertebral disc degeneration
por: Oichi, Takeshi, et al.
Publicado: (2020)

Expression in retinal neurons of fukutin and FKRP, the protein products of two dystroglycanopathy-causative genes
por: Haro, Carmen, et al.
Publicado: (2018)

Saying NO to muscular dystrophy
por: Dove, Alan W.
Publicado: (2001)

Fatigue in muscular dystrophies
por: Angelini, Corrado, et al.
Publicado: (2012)

Cardiac Dysrhythmias, Cardiomyopathy and Muscular Dystrophy in Patients with Emery-Dreifuss Muscular Dystrophy and Limb-Girdle Muscular Dystrophy Type 1B
por: Hong, Jong-Seo, et al.
Publicado: (2005)

Identification of Muscle-Specific MicroRNAs in Serum of Muscular Dystrophy Animal Models: Promising Novel Blood-Based Markers for Muscular Dystrophy
por: Mizuno, Hideya, et al.
Publicado: (2011)

Longitudinal Study of Three microRNAs in Duchenne Muscular Dystrophy and Becker Muscular Dystrophy
por: Trifunov, Selena, et al.
Publicado: (2020)

Genetic Patterns of Selected Muscular Dystrophies in the Muscular Dystrophy Surveillance, Tracking, and Research Network
por: Kang, Peter B., et al.
Publicado: (2023)

Comparative proteomic analyses of Duchenne muscular dystrophy and Becker muscular dystrophy muscles: changes contributing to preserve muscle function in Becker muscular dystrophy patients
por: Capitanio, Daniele, et al.
Publicado: (2020)

Studies of pseudohypertrophic muscular dystrophy
por: Bonsett, Charles A., 1921-
Publicado: (1969)

Autonomic regulation in muscular dystrophy
por: Angelini, Corrado, et al.
Publicado: (2013)

Autonomic regulation in muscular dystrophy
por: Sabharwal, Rasna
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_li35qgg67293292h0q1t62ct13